|
AHR expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
8.615700E-02 |
| Normal-vs-Stage3 |
9.55600043539562E-10 |
| Normal-vs-Stage4 |
1.82038999999579E-05 |
| Stage1-vs-Stage2 |
4.980000E-04 |
| Stage1-vs-Stage3 |
1.279210E-01 |
| Stage1-vs-Stage4 |
2.935600E-01 |
| Stage2-vs-Stage3 |
1.110190E-02 |
| Stage2-vs-Stage4 |
3.023700E-02 |
| Stage3-vs-Stage4 |
9.969400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
5.942700E-03 |
| Normal-vs-Asian |
8.08599999957416E-07 |
| Caucasian-vs-AfricanAmerican |
8.495200E-01 |
| Caucasian-vs-Asian |
6.922400E-01 |
| AfricanAmerican-vs-Asian |
9.775200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.41729999853158E-09 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
6.342100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
3.22553095344347E-12 |
| Normal-vs-Age(61-80Yrs) |
2.636300E-04 |
| Normal-vs-Age(81-100Yrs) |
1.543570E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.160300E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.58318999999851E-05 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.330400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.297600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.053000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.076600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.608000E-01 |
| Classical-VS-Follicular |
1.62436730732907E-12 |
| Classical-VS-Other |
3.479200E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
2.67670330345027E-11 |
| Tall-VS-Other |
1.752770E-01 |
| Tall-VS-Normal |
1.64379999612052E-08 |
| Follicular-VS-Other |
1.727840E-02 |
| Follicular-VS-Normal |
5.205800E-01 |
| Other-VS-Normal |
7.899900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.6737000008149E-08 |
| Normal-vs-N1 |
3.29950000654833E-09 |
| N0-vs-N1 |
7.60300000000047E-05 |
|
|
